Literature DB >> 27757003

Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit.

Huan Mark Nguyen, Doreen Pon.   

Abstract

OBJECTIVE: Evaluate recent clinical studies involving the use of dexmedetomidine (DEX) infusion for the treatment of delirium in the intensive care unit (ICU).
METHODS: A literature search was conducted to identify peer-reviewed articles in MEDLINE (1966-June 2016) using the terms sedation, analgesic, dexmedetomidine, delirium, and critically ill adult patients.
RESULTS: Two studies in the ICU setting reported the potential benefits of DEX for managing agitation during weaning from mechanical ventilation. One pilot study and a clinical trial reported the use of DEX in the treatment of ICU delirium.
CONCLUSION: Further studies are required to evaluate the use of DEX treatment in critically ill patients presenting with delirium.

Entities:  

Keywords:  critically ill patients; delirium; dexmedetomidine

Year:  2016        PMID: 27757003      PMCID: PMC5047002     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  28 in total

Review 1.  Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis.

Authors:  Nada S Al-Qadheeb; Ethan M Balk; Gilles L Fraser; Yoanna Skrobik; Richard R Riker; John P Kress; Shawn Whitehead; John W Devlin
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

2.  Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects.

Authors:  Yahya Shehabi; Urban Ruettimann; Harriet Adamson; Richard Innes; Mathieu Ickeringill
Journal:  Intensive Care Med       Date:  2004-08-26       Impact factor: 17.440

3.  Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium.

Authors:  Jukka Tolonen; Juhani Rossinen; Hannu Alho; Veli-Pekka Harjola
Journal:  Eur J Emerg Med       Date:  2013-12       Impact factor: 2.799

4.  Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal.

Authors:  Jamil Darrouj; Nitin Puri; Erin Prince; Anthony Lomonaco; Antoinette Spevetz; David R Gerber
Journal:  Ann Pharmacother       Date:  2008-09-09       Impact factor: 3.154

Review 5.  Treating agitation with dexmedetomidine in the ICU.

Authors:  Jeanne Boyer
Journal:  Dimens Crit Care Nurs       Date:  2009 May-Jun

6.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

7.  Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically Ill patients: a meta-analysis of randomized controlled trials.

Authors:  Laura Pasin; Giovanni Landoni; Pasquale Nardelli; Alessandro Belletti; Ambra Licia Di Prima; Daiana Taddeo; Francesca Isella; Alberto Zangrillo
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-07-14       Impact factor: 2.628

Review 8.  Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.

Authors:  J Barr; A Donner
Journal:  Crit Care Clin       Date:  1995-10       Impact factor: 3.598

Review 9.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

Review 10.  The importance of diagnosing and managing ICU delirium.

Authors:  Brenda T Pun; E Wesley Ely
Journal:  Chest       Date:  2007-08       Impact factor: 9.410

View more
  1 in total

Review 1.  Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.

Authors:  Ailan Yu; Shanshan Wu; Zongwang Zhang; Tom Dening; Sai Zhao; Gillian Pinner; Jun Xia; Daogui Yang
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.